Model
Edge
Eagle Pharmaceuticals, Inc.
EGRX
Filing type
3
Filing date
Nov 18, 2024
Updated
Nov 19, 2024 ยท 5:59 PM
Copy reference
Filing
3
Initial Statement of Beneficial Ownership